What question did this study set out to answer?

The aim is to explore how mutations in KCNJ10 affect hypokalemia through the involvement of the mTOR pathway in the distal convoluted tubule.

March 27, 2026Open Access

View Full Paper

WCN26-2869 HYPOKALEMIA IN EAST/SESAME SYNDROME: POTENTIAL ROLE OF mTOR PATHWAY

PWPeng WuFirst Affiliated Hospital of Zhengzhou University YYYing YangGeneral Cardiology RZRui-Juan ZhangZhengzhou University

Key Points

The aim is to explore how mutations in KCNJ10 affect hypokalemia through the involvement of the mTOR pathway in the distal convoluted tubule.
Utilized genetic analysis to confirm mutations in KCNJ10.
Investigated Kir4.1 deletion effects in distal convoluted tubule cells.
Examined ENaC activity regulation by mTOR signaling.
Kir4.1 deletion was linked to increased ENaC activity.
mTOR-dependent mechanisms were suggested as mediators of this increase.
Findings indicate a direct role of the mTOR pathway in hypokalemia associated with EAST/SeSAME syndrome.

Abstract

Loss-of-function mutations in KCNJ10, encoding Kir4.1, cause EAST/SeSAME syndrome, with renal salt-wasting tubulopathy and hypokalemia. We hypothesized that Kir4.1 deletion specifically in the distal convoluted tubule (DCT) stimulates epithelial sodium channel (ENaC) activity via the mammalian target of rapamycin (mTOR)-dependent mechanisms, contributing to hypokalemia.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

WCN26-2869 HYPOKALEMIA IN EAST/SESAME SYNDROME: POTENTIAL ROLE OF mTOR PATHWAY

Key Points

Abstract

Cite This Study

Also Consider

Also Consider